LLY - What Company Will Eli Lilly Buy Next?
Targeting smaller "bolt-on" acquisitions in the range of $1 billion to $5 billion, Eli Lilly (NYSE: LLY) plans to expand its research and development pipeline by acquiring a company roughly every quarter. The company's CFO made these comments during the J.P. Morgan Healthcare Conference as he discussed the company's $1.1 billion purchase of Dermira (NASDAQ: DERM).
Image source: Getty Images.
Knowing that the big pharmaceutical company is going shopping, some biotech deal makers and investors looking for exits hope their companies will be snapped up next. Here we will explore a few companies that could be on Lilly's shopping list.